日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Idarubicin-loaded chitosan nanobubbles to improve survival and decrease drug side effects in hepatocellular carcinoma.

载有伊达比星的壳聚糖纳米泡可提高肝细胞癌患者的生存率并减少药物副作用

期刊:Nanomedicine
影响因子:3.9
doi:10.1080/17435889.2025.2452154
Mossenta Monica, Argenziano Monica, Capolla Sara, Busato Davide, Durigutto Paolo, Mangogna Alessandro, Polano Maurizio, Sblattero Daniele, Cavalli Roberta, Macor Paolo, Toffoli Giuseppe, Dal Bo Michele
细胞生物学
发表日期：2025
文献求助 收藏

The Proteoglycan Glypican-1 as a Possible Candidate for Innovative Targeted Therapeutic Strategies for Pancreatic Ductal Adenocarcinoma

蛋白聚糖 Glypican-1 作为胰腺导管腺癌创新靶向治疗策略的潜在候选药物

期刊:International Journal of Molecular Sciences
影响因子:4.9
doi:10.3390/ijms231810279
Busato, Davide; Mossenta, Monica; Dal Bo, Michele; Macor, Paolo; Toffoli, Giuseppe
肿瘤免疫
肿瘤
发表日期：2022
文献求助 收藏

Novel Nanotechnology Approaches to Overcome Drug Resistance in the Treatment of Hepatocellular Carcinoma: Glypican 3 as a Useful Target for Innovative Therapies

利用新型纳米技术克服肝细胞癌治疗中的耐药性：Glypican 3 作为创新疗法的有效靶点

期刊:International Journal of Molecular Sciences
影响因子:4.9
doi:10.3390/ijms231710038
Mossenta, Monica; Busato, Davide; Dal Bo, Michele; Macor, Paolo; Toffoli, Giuseppe
细胞生物学
肿瘤
肿瘤免疫
发表日期：2022
文献求助 收藏

New Insight into Therapies Targeting Angiogenesis in Hepatocellular Carcinoma

肝细胞癌血管生成靶向治疗的新见解

期刊:Cancers
影响因子:4.4
doi:10.3390/cancers11081086
Mossenta, Monica; Busato, Davide; Baboci, Lorena; Cintio, Federica Di; Toffoli, Giuseppe; Bo, Michele Dal
肿瘤
肿瘤免疫
Angiogenesis
细胞生物学
血管生成
发表日期：2019
文献求助 收藏